India markets closed
  • BSE SENSEX

    47,949.42
    -882.61 (-1.81%)
     
  • Nifty 50

    14,359.45
    -258.40 (-1.77%)
     
  • Dow

    34,074.30
    -126.37 (-0.37%)
     
  • Nasdaq

    14,035.39
    -16.95 (-0.12%)
     
  • BTC-INR

    4,243,987.00
    +139,964.50 (+3.41%)
     
  • CMC Crypto 200

    1,283.61
    -15.35 (-1.18%)
     
  • Hang Seng

    29,106.15
    +136.44 (+0.47%)
     
  • Nikkei

    29,685.37
    +2.00 (+0.01%)
     
  • EUR/INR

    90.1086
    +0.8358 (+0.94%)
     
  • GBP/INR

    104.5741
    +1.5590 (+1.51%)
     
  • AED/INR

    20.3460
    +0.1130 (+0.56%)
     
  • INR/JPY

    1.4423
    -0.0154 (-1.06%)
     
  • SGD/INR

    56.2700
    +0.4350 (+0.78%)
     

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Five Prime Therapeutics, Inc. Buyout

Rigrodsky Law, P.A
·1-min read

WILMINGTON, Del., March 04, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Five Prime Therapeutics, Inc. (“Five Prime”) (NASDAQ GS: FPRX) regarding possible breaches of fiduciary duties and other violations of law related to Five Prime’s agreement to be acquired by Amgen Inc. (“Amgen”) (NASDAQ GS: AMGN). Under the terms of the agreement, Five Prime’s shareholders will receive $38.00 in cash per share.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-five-prime-therapeutics-inc.

You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com.

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

CONTACT:

Rigrodsky Law, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free)
(302) 295-5310
Fax: (302) 654-7530
info@rl-legal.com
https://rl-legal.com